Published in
Elsevier, Biomedicine and Pharmacotherapy, (145), p. 112455, 2022
DOI: 10.1016/j.biopha.2021.112455
Links
Tools
Empagliflozin adjunct with metformin for the inhibition of hepatocellular carcinoma progression: Emerging approach for new application
Journal article published in 2022 by
Amir Mohamed Abdelhamid,
Sameh Saber,
Mahmoud E. Youssef,
Ahmed Gaafar Ahmed Gaafar,
Hanan Eissa,
Marwa A. Abd-Eldayem,
Mohammed Alqarni,
Gaber El-Saber Batiha,
Ahmad J. Obaidullah 
,
Mohamed Awad Shahien,
Eman El-Ahwany,
Noha A. Amin,
Mohamed Ali Etman,
Mohamed M. Y. Kaddah,
Eslam E. Abd El-Fattah
,
Mohamed Awad Shahien,
Eman El-Ahwany,
Noha A. Amin,
Mohamed Ali Etman,
Mohamed M. Y. Kaddah,
Eslam E. Abd El-Fattah
This paper is made freely available by the publisher.
Full text: Download
Data provided by 